Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of management of rheumatoid arthritis in children. We have Dr Suma Balan, Dr Sikha Agarwal, Dr Vignesh P, and Dr Chandrika Bhat to lead the session.
Rheumatoid arthritis is an autoimmune disease which usually affects a majority of the adult population causing severe pain due to the stiffness of the joints, and affecting the mobility of the joints. However, this webinar is going to give you a broader idea on the occurrence of rheumatoid arthritis in children.
A detailed discussion is provided on the occurrence and management of rheumatoid arthritis in children. In this webinar they have discussed different types of arthritis observed in children which include juvenile idiopathic arthritis, oligoarthritis, enthesitis-related arthritis (ERA) etc.
Also learn how the TNF alpha inhibitors and JAK inhibitors play a key role in altering immune responses in rheumatoid arthritis.
Thus, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
2.
High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?
3.
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic
4.
The pandemic had little impact on mental health symptoms.
5.
How breast tissue density affects your risk of breast cancer
1.
Uncovering Breast Cancer: The Power of Early Stage Ultrasound
2.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
3.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
4.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
5.
Patient-Centric Approaches in Hematology: Integrating Individualized Care into Modern Clinical Practice
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation